Matthias Ebert

650 total citations
17 papers, 377 citations indexed

About

Matthias Ebert is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Matthias Ebert has authored 17 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Matthias Ebert's work include Neuroendocrine Tumor Research Advances (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Neuroblastoma Research and Treatments (3 papers). Matthias Ebert is often cited by papers focused on Neuroendocrine Tumor Research Advances (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Neuroblastoma Research and Treatments (3 papers). Matthias Ebert collaborates with scholars based in Germany, Switzerland and United States. Matthias Ebert's co-authors include Albert Roessner, Christoph Röcken, Uwe Lendeckel, Stacy Carl-McGrath, Helmut Friess, H. G. Beger, Bertram Poch, W. Mohr, Toshihide Imaizumi and Markus W. Büchler and has published in prestigious journals such as Gastroenterology, Cancer and The American Journal of Surgery.

In The Last Decade

Matthias Ebert

16 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Ebert Germany 8 235 124 102 78 71 17 377
Carla Pecchioni Italy 10 159 0.7× 141 1.1× 107 1.0× 67 0.9× 36 0.5× 12 384
Brunhilde Chaloupka Germany 13 282 1.2× 142 1.1× 155 1.5× 75 1.0× 103 1.5× 14 482
Ahmed Bedeir United States 7 147 0.6× 106 0.9× 87 0.9× 42 0.5× 30 0.4× 9 300
Hiroyuki Konno Japan 9 199 0.8× 25 0.2× 138 1.4× 21 0.3× 81 1.1× 9 333
Katsuya Morimatsu Japan 11 280 1.2× 46 0.4× 105 1.0× 15 0.2× 149 2.1× 13 368
F. Sciarretta Italy 8 153 0.7× 24 0.2× 74 0.7× 16 0.2× 96 1.4× 17 321
Hitomi Sakamoto Japan 9 114 0.5× 47 0.4× 122 1.2× 15 0.2× 59 0.8× 11 312
Bénédicte Thuille France 5 272 1.2× 74 0.6× 271 2.7× 72 0.9× 58 0.8× 8 668
Modesto DʼAprile Italy 12 272 1.2× 85 0.7× 89 0.9× 36 0.5× 31 0.4× 34 399
Yanfen Ye China 9 151 0.6× 66 0.5× 272 2.7× 72 0.9× 52 0.7× 9 489

Countries citing papers authored by Matthias Ebert

Since Specialization
Citations

This map shows the geographic impact of Matthias Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Ebert more than expected).

Fields of papers citing papers by Matthias Ebert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Ebert. The network helps show where Matthias Ebert may publish in the future.

Co-authorship network of co-authors of Matthias Ebert

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Ebert. A scholar is included among the top collaborators of Matthias Ebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Ebert. Matthias Ebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ettrich, Thomas J., Matthias Ebert, Sylvie Lorenzen, et al.. (2018). ASCO- und ESMO-Update 2017 – Neuigkeiten vom 53. Meeting der American Society of Clinical Oncology/ASCO 2017 und European Society for Medical Oncology/ESMO-Congress 2017. Zeitschrift für Gastroenterologie. 56(4). 384–397. 4 indexed citations
2.
Frilling, Andrea & Matthias Ebert. (2015). Treatment of Non-Colorectal Liver Metastases. Visceral Medicine. 31(6). 386–386. 1 indexed citations
3.
Ebert, Matthias, et al.. (2012). Treatment of Hepatocellular Carcinoma with Sorafenib - Focus on Special Populations and Adverse Event Management. Zeitschrift für Gastroenterologie. 50(9). 1018–1027. 10 indexed citations
4.
Carl-McGrath, Stacy, Uwe Lendeckel, Matthias Ebert, Albert Roessner, & Christoph Röcken. (2005). The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. International Journal of Oncology. 26(1). 17–24. 138 indexed citations
5.
Rickes, Steffen, Kerstin Schütte, Matthias Ebert, & Peter Malfertheiner. (2004). Spoke-Like Vascular Pattern – A Characteristic Sign of Focal Nodular Hyperplasias in the Liver. Digestive Diseases. 22(1). 92–93. 1 indexed citations
6.
Dierkes, Jutta, Matthias Ebert, Peter Malfertheiner, & Claus Luley. (2003). <i>Helicobacter pylori</i> Infection, Vitamin B<sub>12</sub> and Homocysteine. Digestive Diseases. 21(3). 237–244. 19 indexed citations
7.
Leodolter, Andreas, K. Wolle, U Peitz, et al.. (2003). Helicobacter pylori Genotypes and Expression of Gastritis in Erosive Gastro-oesophageal Reflux Disease. Scandinavian Journal of Gastroenterology. 38(5). 498–502. 16 indexed citations
8.
Leodolter, Andreas, Matthias Ebert, Stefan Kahl, Michael Vieth, & Peter Malfertheiner. (2003). Age-dependent prevalence of H. pylori associated gastritis phenotypes with increased risk for gastric cancer. Gastroenterology. 124(4). A648–A649. 1 indexed citations
9.
Ebert, Matthias, et al.. (2000). Overexpression of transforming growth factor beta-1 (TGF-B1) is associated with reduced pten expression in pancreatic fibrosis and cancer. Gastroenterology. 118(4). A650–A650. 2 indexed citations
10.
Ridwelski, Karsten, et al.. (2000). Reduced PTEN expression in gastric cancer and in the mucosa of gastric cancer relatives. Gastroenterology. 118(4). A58–A59. 1 indexed citations
11.
Friess, Helmut, et al.. (1999). Molekulare Veränderungen bei Pankreas- und periampullären Karzinomen. Visceral Medicine. 15(2). 150–157. 2 indexed citations
12.
Hsiang, David, et al.. (1997). Absence of K-ras mutations in the pancreatic parenchyma of patients with chronic pancreatitis. The American Journal of Surgery. 174(3). 242–246. 26 indexed citations
13.
Yokoyama, Munehiro, Matthias Ebert, Hitoshi Funatomi, et al.. (1995). AMPHIREGULIN IS A POTENT MITOGEN IN HUMAN PANCREATIC-CANCER CELLS - CORRELATION WITH PATIENT SURVIVAL. International Journal of Oncology. 6(3). 625–31. 21 indexed citations
14.
Korc, Murray, Helmut Frieß, Michael S. Kobrin, Matthias Ebert, & Markus W. Büchler. (1994). Growth Factors in Human Pancreatic Cancer: Update on the Role of the Epidermal Growth Factor Receptor. Digestive Surgery. 11(3-6). 147–149. 3 indexed citations
15.
Ebert, Matthias, Helmut Frieß, H. G. Beger, & M.W. Büchler. (1994). Role of Octreotide in the Treatment of Pancreatic Cancer. Digestion. 55(1). 48–51. 27 indexed citations
16.
Büchler, Markus W., Helmut Friess, Bertram Poch, et al.. (1994). Carcinoid of the ampulla of vater. Clinical characteristics and morphologic features. Cancer. 73(6). 1580–1588. 104 indexed citations
17.
Ferguson, Sherry A., Gary W. Kraemer, Robert E. Bowman, Dennis E. Schmidt, & Matthias Ebert. (1993). Lack of effect of chronic developmental lead treatment on biogenic amines and metabolites in monkey cerebrospinal fluid. Neurotoxicology and Teratology. 15(4). 229–235. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026